Daflon 1000 mg

Daflon is a widely recognized phlebotropic medication used primarily to treat symptoms related to chronic venous insufficiency and hemorrhoidal disease. The drug is composed of a micronized purified flavonoid fraction (MPFF), which enhances its absorption and efficacy in strengthening blood vessel walls and improving circulation.

Originally developed in France by Les Laboratoires Servier, Daflon has become a global benchmark in vascular health. While the core research and development were established in France, Servier maintains a significant global manufacturing footprint. In Russia, for example, the company operates a major production facility in Moscow (Sopharma/Servier), ensuring local supply for the regional market.

Servier remains an independent, international pharmaceutical company governed by a non-profit foundation. This unique ownership structure allows the company to reinvest a large portion of its turnover into research and development, maintaining its position as the ultimate owner and manufacturer of the Daflon brand worldwide.